Two sons remained unaffected, while two were inflicted with hemophilia but both died childless. This disease results from a genetic mutation that is passed down through generations. The frequency ...

Hemophilia C is an autosomal inherited form of the disease. It affects biological males and females equally because the genetic defect that causes this type of hemophilia isn’t related to sex ...

World Hemophilia Day 2025 is observed annually7. Candidates can refer to this post for to know more about the theme, support ...

Hemophilia is a genetic bleeding disorder where the blood doesn't clot properly due to a deficiency of clotting factors.

Hemophilia represents a rare, lifelong bleeding disorder characterized by the blood's inability to clot normally. While management strategies have advanced ...

The hemophilia treatment market in Japan is expected to witness steady growth during the forecast period, with a projected CAGR of 6.16% from 2025 to 2033. By the end of this period, the market is ...

thus making the clot weak and unstable Approximately one third of patients with hemophilia have no family history of the disease, either because of new genetic mutations, or because previous ...

World Hemophilia Day 2025 highlights global awareness and calls for inclusive care for everyone affected by bleeding ...

Dr. Ma. Leah Floirendo (left) and Dr. Jaymart Costillas (right) of Northern Mindanao Medical Center emphasize the importance ...

The FDA has approved fitusiran, now named Qfitlia, for routine prophylaxis in patients aged 12 and older with hemophilia A or B, with or without inhibitors. Qfitlia offers less ...

The gene therapy BBM-H901 (dalnacogene ponparvovec) has been approved in China for adults with moderate to severe hemophilia ...

World Hemophilia Day, April 17, will focus on diagnosis and treatment access for women and girls, the World Federation for Hemophilia said.